XML 19 R4.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Total revenue $ 838,142 $ 1,274,499 $ 1,010,663
Costs and expenses:      
Cost of product revenue 430,750 506,530 662,747
Research and development 11,908,294 16,989,911 20,378,161
Selling, general and administrative 10,573,321 18,503,684 19,855,987
Total costs and expenses 22,912,365 36,000,125 40,896,895
Loss from operations (22,074,223) (34,725,626) (39,886,232)
Interest income, net 152,006 291,964 393,109
Net loss (21,922,217) (34,433,662) (39,493,123)
Net loss attributable to common stockholders $ (21,922,217) $ (34,433,662) $ (39,493,123)
Net loss per share attributable to common stockholders - basic and diluted (in usd per share) $ (1.22) $ (1.99) $ (2.43)
Weighted-average number of common shares outstanding — basic and diluted (shares) 18,016,841 17,260,626 16,233,985
Net product revenue      
Total revenue $ 826,515 $ 1,260,973 $ 989,918
Other revenue      
Total revenue $ 11,627 $ 13,526 $ 20,745